Glucosaminylmuramyl dipeptide potentiates the effects of tumor necrosis factor-α and cisplatin on transformed cellsin vitro
✍ Scribed by E. E. Petrova; T. I. Valyakina; R. L. Komaleva; M. A. Simonova; V. A. Nesmeyanov
- Publisher
- Springer US
- Year
- 2007
- Tongue
- English
- Weight
- 371 KB
- Volume
- 143
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Lovastatin, a drug commonly used in the treatment of hypercholesterolemia, has previously been reported to exert potentiated antitumor activity when combined with either tumor necrosis factor-␣ (TNF-␣), cisplatin or doxorubicin in a melanoma model in mice. Since lovastatin interferes with the functi
The effect of (0.05 ng ml-1 and 0.1 ng ml(-1)) TNF alpha on the phospholipid metabolism of Tetrahymena pyriformis was studied. The amount of phosphatidyl choline (PC), phosphatidyl inositol (PI), phosphatidic acid (PA), phosphatidyl ethanolamine (PE), diacylglycerol (DAG), arachidonic acid (AA) and
The anti-tumor effects of actinomycin D (Act D) and recombinant human tumor necrosis factor (TNF)-a have been studied on 4 established murine tumor cell lines: MmBI6 melanoma, Lewis lung (LL/2) carcinoma, L I sarcoma and L I 2 10 leukemia. During short-term incubation (24 hr) Act D produced dosedepe
One of the biological functions of lactoferrin is the modulation of the host defense systems, including cytokine production and immune responses. We have tested the effect of lactoferrin on the productions of tumor necrosis factor-␣ and nitric oxide in some cells. Lactoferrin itself did not induce e